Association between benign thyroid disease and breast cancer: a single center experience

BMC Endocr Disord. 2019 Oct 17;19(1):104. doi: 10.1186/s12902-019-0426-8.

Abstract

Background: The relationship between breast cancer (BC) and thyroid disease (TD) is still controversial. The aim of the study was to investigate the possible coexistence of TD in patients with newly diagnosed BC and its correlation with BC clinical presentation with regard to menopausal status and stage of disease.

Methods: This is a retrospective cohort study of all patients treated for primary BC between 2014 and 2016 at the Breast Unit of Trieste University Hospital. Clinical charts and reports were reviewed for coexisting thyroid disorders (i.e. hyperthyroidism, hypothyroidism, benign TD, thyroid cancer, thyroid autoimmunity) and menopausal status at the time of BC diagnosis. Biomolecular profile, stage, and grading of BC were also evaluated.

Results: A total of 786 women and 7 men were included in the study. Co-presence of TD was found in 161(20.3%) cases: of these, 151(19.4%) patients presented benign TD and 10(1.3%) patients presented thyroid carcinoma. Thyroid autoimmunity was found in 51(32%) patients. Regarding thyroid function, 88(55%) patients had hypothyroidism, 19(12%) hyperthyroidism, and 54(33%) normal thyroid function. No statistically significant correlation was found between age and TD (p = 0.16), although TD was more common in women aged ≥60 years. Women with BC diagnosed at pre-menopausal age were more likely to have thyroid autoimmune diseases (45% vs. 29%, p = 0.05). No association was detected among BC molecular profiles with either thyroid autoimmunity (p = 0.26) or altered thyroid function (p = 0.63). High-grade BC was more frequent in women with hyperthyroidism (52.9%, p = 0.04), but the grading was independent from the presence of thyroid autoimmune disease (p = 0.87). BC stage was related to both thyroid autoimmunity (p = 0.04) and thyroid function (p < 0.001), with 55.2% of women affected by benign TD presenting with stage I BC and more aggressive BCs found in hypothyroid patients.

Conclusions: According our study results, patients with primary BC present a greater incidence of autoimmunity disorders, especially when diagnosed in the pre-menopausal setting. However, further prospective studies are required to definitively prove causality.

Keywords: Benign thyroid disease; Breast cancer; Menopause; Thyroid disorders.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Biomarkers / analysis*
  • Breast Neoplasms / classification
  • Breast Neoplasms / complications*
  • Breast Neoplasms / diagnosis*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Prognosis
  • Retrospective Studies
  • Thyroid Diseases / classification
  • Thyroid Diseases / complications*
  • Thyroid Diseases / diagnosis*
  • Thyroid Function Tests

Substances

  • Biomarkers